Bromodomain and extra-terminal (BET) inhibitor INCB057643 in patients with relapsed or refractory myelofibrosis (MF) and other advanced myeloid neoplasms: A phase 1 study

被引：0

作者：

Watts, Justin M.

Vannucchi, Alessandro M.

Hunter, Anthony

McMahon, Brandon

Tantravahi, Srinivas Kiran

Iurlo, Alessandra

Xicoy, Blanca

Palandri, Francesca

Searle, Emma

Reeves, Brandi

Bose, Prithviraj

Diaz, Rosa Ayala

Halpern, Anna B.

Chen, Xuejun

Burke, Lea Micaletti

Zhou, Feng

Zheng, Fred

Vachhani, Pankit

机构：

[1] Sylvester Canc Ctr, Miami, FL USA

[2] Univ Florence, AOU Careggi, Florence, Italy

[3] Emory Univ, Sch Med, Atlanta, GA USA

[4] Univ Colorado Anschutz Med Campus, Aurora, CO USA

[5] Univ Utah, Huntsman Canc Inst, Div Hematol & Hematol Malignancies, Salt Lake City, UT USA

[6] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy

[7] Univ Autonoma Barcelona, Inst Catal Oncol, Josep Carreras Leukemia Res Inst, Hosp Germans Trias & Pujol, Barcelona, Spain

[8] Univ Bologna, Ist Ematol S Orsola Malpighi, IRCCS Azienda Osped, Bologna, Italy

[9] Univ Manchester, Manchester, Lancs, England

[10] Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC USA

[11] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA

[12] Hosp Univ 12 Octubre, Madrid, Spain

[13] Univ Washington, Div Hematol, Fred Hutchinson Canc Ctr, Med Ctr, Seattle, WA USA

[14] Incyte Corp, Wilmington, DE USA

[15] UAB, ONeal Comprehens Canc Ctr, Birmingham, AL USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

6576

引用

页数：1